.Merck & Co.'s TIGIT system has gone through another trouble. Months after shuttering a phase 3 m...
.After a year determined by pipe hairstyles, the shift of its own CEO and discharges, Exscientia wil...
.Cullinan Therapy was excited sufficient along with Harbour BioMed's bispecific immune system reacto...
.Within this full week's episode of "The Best Line," we are actually diving right into Strong Biotec...
.The confetti is actually still soaring from Eli Lilly's event celebrating the approval of Alzheimer...
.Invite to today's Chutes & Ladders, our summary of notable leadership hirings, firings and retir...
.Observing an inadequate revealing for Lykos Rehabs' MDMA prospect for trauma at a latest FDA adviso...
.AN2 Rehabs is actually reviewing its own business in action to lackluster midphase data, vowing to ...
.Merck & Co. is actually paying for $700 million in advance to test Amgen in a blood stream cance...
.With Gilead Sciences almost an FDA choice for its own liver ailment medication seladelpar, the firm...